CORMEDIX INC. news, videos and press releases
For more news please use our advanced search feature.
CORMEDIX INC. - More news...
CORMEDIX INC. - More news...
- CorMedix Inc. Announces Pricing of Public Offering of Common Stock
- CorMedix Inc. Announces Proposed Public Offering of Common Stock
- CorMedix inc. Announces Customer Implementation
- CorMedix Inc. To Participate In The Jefferies Global Healthcare Conference
- CorMedix Inc. to Participate in the RBC Global Healthcare Conference
- CorMedix Inc. Reports First Quarter 2025 Financial Results and Provides Business Update
- CorMedix Inc. to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 6, 2025
- Cormedix Inc. Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales Guidance
- CorMedix Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference
- CorMedix Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
- CorMedix Inc. to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 25, 2025
- CorMedix Announces Collaboration for DefenCath Promotion to the VA and Other Federal Facilities
- CorMedix Inc. Announces Preliminary Fourth Quarter 2024 Results and Provides Business Update
- CorMedix Inc. Added to Nasdaq Biotechnology Index
- CorMedix Inc. Supports CMS Policy Updates Regarding Access to Innovative Drug Products
- CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium
- CorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update
- CorMedix Inc. Announces New Data at ASN Kidney Week 2024
- CorMedix Inc. to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on October 30, 2024
- CorMedix Announces New Commercial Agreement with Mid-Sized Dialysis Operator
- CorMedix Inc. Announces New Commercial Agreement
- CorMedix Inc. to Present at the Cantor Global Healthcare Conference
- CorMedix Inc. Announces New Commercial Agreement
- CorMedix Inc. Reports Second Quarter and Six Month 2024 Financial Results and Provides Business Update
- CorMedix Inc. to Report Second Quarter 2024 Financial Results and Provide a Corporate Update on August 14, 2024
- CorMedix Inc. Announces Outpatient Availability of DefenCath
- CorMedix Inc. Receives FDA Feedback on Potential Label Expansion
- CorMedix Inc. Announces CMS Grants Pass-Through Status to Defencath
- CorMedix Inc. Announces Commercial Agreement With Top Tier Dialysis Provider
- CorMedix Inc. to Participate in Two Upcoming Investor Conferences
